Rhinitis in Children: Current Aspects of Diagnosis and Treatment
https://doi.org/10.15690/pf.v13i2.1556
Abstract
The article is devoted to one of the most urgent problems of pediatrics — rhinitis in children. The difficulty of nasal breathing, being one of the most frequent complaints to pediatricians, can be caused by a banal respiratory infection, as well as be one of the systemic pathology’s symptoms. The economic burden of rhinitis is great for any health budget, the total direct and indirect costs are huge. The article shows the main phenotypic characteristics of rhinitis depending on the etiological factor; gives the modern principles of differential diagnostic search; points studies, use of which is not recommended in routine practice. The authors reflect the key components of a complex therapy and discuss in detail the tactics and possible pharmacological treatment strategies.
About the Authors
E. A. Vishneva
Scientific Center of Children’s Health, Moscow, Russian Federation
Russian Federation
Russian Federation
L. S. Namazova-Baranova
Scientific Center of Children’s Health, Moscow, Russian Federation
I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation
Pirogov Russian National Research Medical University, Moscow, Russian Federation
Russian Federation
Russian Federation
L. R. Selimzyanova
Scientific Center of Children’s Health, Moscow, Russian Federation
Pirogov Russian National Research Medical University, Moscow, Russian Federation
Russian Federation
Russian Federation
A. A. Alekseeva
Scientific Center of Children’s Health, Moscow, Russian Federation
I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation
Russian Federation
Russian Federation
References
1. Beule A. Epidemiology of chronic rhinosinusitis, selected risk factors, comorbidities, and economic burden. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2015;14:Doc11. doi: 10.3205/cto000126.
2. Fokkens WJ, Lund VJ, Mullol J, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012;50(1):1–12.
3. Akdis CA, Hellings PW, Agache I, editors. Global atlas of allergic rhinitis and chronic rhinosinusitis [Internet]. European Academy of Allergy and Clinical Immunology; 2015. 422 p. [cited 2016 Apr 16]. Available from: http://www.eaaci.org/globalatlas/ENT_Atlas_web.pdf.
4. Федеральные клинические рекомендации по оказанию медицинской помощи детям с острой респираторной вирусной инфекцией (острый назофарингит) [интернет]. М.: Союз педиатров России; 2015 [доступ от 26.04.2016]. [Federal’nye klinicheskie rekomendatsii po okazaniyu meditsinskoi pomoshchi detyam s ostroi respiratornoi virusnoi infektsiei (ostryi nazofaringit). Moscow: Soyuz pediatrov Rossii; 2015. (In Russ).] Доступ по ссылке http://www.pediatr-russia.ru/sites/default/files/file/kr_onaz.pdf.
5. Roberts G, Xatzipsalti M, Borrego LM, et al. Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology. Allergy. 2013;68(9):1102–1116. doi: 10.1111/all.12235.
6. Вишнёва Е.А., Намазова-Баранова Л.С., Алексеева А.А. и др. Современные принципы терапии аллергического ринита у детей // Педиатрическая фармакология. — 2014. — Т. 11. — № 1. — С. 6–14. [Vishneva EA, Namazova-Baranova LS, Alekseeva AA, et al. Modern principles of allergic rhinitis therapy in children. Pediatricheskaya farmakologiya. 2014;11(1):6–14. (In Russ).] doi: 10.15690/pf.v11i1.889.
7. Papadopoulos NG, Bernstein JA, Demoly P, et al. Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report. Allergy. 2015;70(5):474–494. doi: 10.1111/all.12573.
8. Molgaard E, Thomsen SF, Lund T, et al. Differences between allergic and nonallergic rhinitis in a large sample of adolescents and adults. Allergy. 2007;62(9):1033–1037. doi: 10.1111/j.1398-9995.2007.01355.x.
9. Settipane RA, Charnock DR. Epidemiology of rhinitis: allergic and nonallergic. Clin Allergy Immunol. 2007;19:23–34.
10. Bousquet J, Fokkens W, Burney P, et al. Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper. Allergy. 2008;63(7):842–853. doi: 10.1111/j.1398-9995.2008.01715.x.
11. Heikkinen T, Jarvinen A. The common cold. Lancet. 2003; 361(9359):782. doi: 10.1016/s0140-6736(03)12637-2.
12. Таточенко В.К. Болезни органов дыхания у детей. — М.: ПедиатрЪ; 2012. 479 с. [Tatochenko VK. Bolezni organov dykhaniya u detei. Moscow: Pediatr; 2012. 479 p. (In Russ).]
13. Akdis CA, Agache I, editors. Global atlas of allergy [Internet]. European Academy of Allergy and Clinical Immunology; 2014. 13 p [cited 2016 Apr 20]. Available from: http://www.allergique.org/IMG/Global_Atlas_of_Allergy.pdf.
14. Федеральные клинические рекомендации по оказанию медицинской помощи детям с аллергическим ринитом [интернет]. М.: Союз педиатров России; 2015 [доступ от 26.04.2016]. [Federal’nye klinicheskie rekomendatsii po okazaniyu meditsinskoi pomoshchi detyam s allergicheskim rinitom. Moscow: Soyuz pediatrov Rossii; 2015. (In Russ).] Доступ по ссылке http://pediatr-russia.ru/sites/default/files/file/kr_ar.pdf.
15. Chow AW, Benninger MS, Brook I, et al. Executive summary: IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis. 2012;54(8):72–112. doi: 10.1093/cid/cir1043.
16. Bousquet J, Schunemann HJ, Fonseca J, et al. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. Allergy. 2015;70(11):1372–1392. doi: 10.1111/all.12686.
17. Баранов А.А., Намазова-Баранова Л.С., Смирнов И.В. и др. Методы и средства комплексного интеллектуального анализа медицинских данных // Труды Института системного анализа РАН. — 2015. — Т. 65. — № 2. — С. 81–93. [Baranov AA, Namazova-Baranova LS, Smirnov IV, et al. Methods and systems for data and text mining in healthcare. Trudy Instituta sistemnogo analiza RAN. 2015;65(2):81—93. (In Russ).]
18. Баранов А.А., Вишнёва Е.А., Намазова-Баранова Л.С. Телемедицина — перспективы и трудности перед новым этапом развития // Педиатрическая фармакология. — 2013. — Т. 10. — № 3. — С. 6–11. [Baranov AA, Vishneva EA, Namazova-Baranova LS. Telemedicine — prospects and difficulties before a new development stage. Pediatricheskaya farmakologiya. 2013;10(3): 6–11. (In Russ).] doi: 10.15690/pf.v10i3.691.
19. Намазова-Баранова Л.С., Суворов Р.Е., Смирнов И.В., и др. Управление рисками пациента на основе технологий удаленного мониторинга здоровья: состояние области и перспективы //Вестник РАМН. — 2015. — Т. 70. — № 1. — С. 82–89. [Namazova- Baranova LS, Suvorov RE, Smirnov IV, et al. Risk management of a patient on the basis of remote health monitoring: current situation and prospects. Vestn Ross Akad Med Nauk. 2015;70(1):82–89. (In Russ).] doi: 10.15690/vramn.v70i1.1235.
20. Ассоциация врачей общей практики (семейных врачей) Российской Федерации. Острый синусит. Клинические рекомендации для врачей общей практики (семейных врачей). — М.; 2014. [Assotsiatsiya vrachei obshchei praktiki (semeinykh vrachei) Rossiiskoi Federatsii. Ostryi sinusit. Klinicheskie rekomendatsii dlya vrachei obshchei praktiki (semeinykh vrachei). Moscow; 2014. (In Russ).]
21. Zalmanovici Trestioreanu A, Yaphe J. Intranasal steroids for acute sinusitis. Cochrane Database Syst Rev. 2013;(12):CD005149. doi: 10.1002/14651858.CD005149.pub4.
22. http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/03/news_detail_002500.jsp&mid=WC0b01ac058001d126
23. Adverse drug reactions of systemic antihistamines in children in the Netherlands // Archives of Disease in Childhood, 2016, doi:10.1136/archdischild-2015-310315
24. Stelmach I, Ozarek-Hanc A, Zaczeniuk M, et al. Do children with stable asthma benefit from addition of montelukast to inhaled corticosteroids: Randomized, placebo controlled trial. Pulm Pharmacol Ther. 2015;31:42–48. doi: 10.1016/j.pupt.2015.01.004.
25. Вишнёва Е.А., Намазова-Баранова Л.С., Алексеева А.А., и др. Детская астма: ключевые принципы достижения контроля на современном этапе // Педиатрическая фармакология. — 2013. — Т. 10. — №4. — С. 60–72. [Vishneva EA, Namazova- Baranova LS, Alekseeva AA, et al. Infant asthma: key principles of control attainment in the modern stage. Pediatricheskaya farmakologiya. 2013;10(4):60—72. (In Russ).] doi: 10.15690/ pf.v10i4.756.
26. Shokouhi F, Meymaneh Jahromi A, Majidi MR, Salehi M. Montelukast in adenoid hypertrophy: its effect on size and symptoms. Iran J Otorhinolaryngol. 2015;27(83):443–448.
27. Kar M, Altintoprak N, Muluk NB, et al. Antileukotrienes in adenotonsillar hypertrophy: a review of the literature. Eur Arch Otorhinolaryngol [Internet]. 2016 Mar 16:[1–7]. doi: 10.1007/s00405-016-3983-8. Available from: http://link.springer.com/article/10.1007%2Fs00405-016-3983-8.
28. Ince I, Yoruk O, Ahiskalioglu A, et al. Does Montelukast have an effect on post-tonsillectomy pain control in children? A randomized trial study. Otolaryngol Head Neck Surg. 2015;153(2):269–274. doi: 10.1177/0194599815580976.
29. Митюшин И.Л., Таточенко В.К., Бурцева Е.И., и др. Эпидемиологическая эффективность инактивированной субъединичной гриппозной вакцины Инфлювак у детей // Детский доктор. — 2001. — № 5–6. — С. 39–44. [Mityushin IL, Tatochenko VK, Burtseva EI, et al. Epidemiologicheskaya effektivnost’ inaktivirovannoi sub”edinichnoi grippoznoi vaktsiny Inflyuvak u detei. Detskii doktor. 2001;(5–6):39–44. (In Russ).]
Review
For citations:
Vishneva E.A., Namazova-Baranova L.S., Selimzyanova L.R., Alekseeva A.A. Rhinitis in Children: Current Aspects of Diagnosis and Treatment. Pediatric pharmacology. 2016;13(2):149-157. (In Russ.) https://doi.org/10.15690/pf.v13i2.1556
Views:
1114
Email this article 